Real-World Outcomes of First-Line Chemotherapy in Metastatic Pancreatic Cancer: A Nationwide Population-Based Study in Korea
Patients with mPC receiving chemotherapy have shown improved OS since the introduction of GnP and FOLFIRINOX. After matching, OS did not differ between the GnP and FOLFIRINOX groups.
Authors
- Kang Ju Son
- Kyong Joo Lee (ORCID: https://orcid.org/0000-0002-9175-9164)
- Byung Kyu Park (ORCID: https://orcid.org/0000-0002-6801-3831)
- Joung‐Ho Han (ORCID: https://orcid.org/0000-0003-4469-9215)
- Chan Su Park (ORCID: https://orcid.org/0000-0003-1805-7382)
Institutions
- Chungbuk National University (KR)
- National Health Insurance Service Ilsan Hospital (KR)
- Hallym University Dongtan Sacred Heart Hospital (KR)
- National Health Insurance Service (KR)
Publication Details
- Journal
- Cancers
- Published
- 2024-09-16
- DOI
- https://doi.org/10.3390/cancers16183173
- Citations
- 5
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 1.41
Funders
- National Health Insurance Service
- NATIONAL HEALTH INSURANCE SERVICE ILSANHOSPITAL